Hisun-Pfizer Pharmaceuticals' Corporate Minority Round

Hisun-Pfizer Pharmaceuticals raised a round of funding on November 12, 2017. Investors include Sapphire Holdings.

Hisun-Pfizer Pharmaceuticals is a joint venture between Pfizer and China's Zhejiang Hisun Pharmaceuticals created in 2012 to develop and market generic drugs.…

Articles about Hisun-Pfizer Pharmaceuticals' Corporate Minority Round: